I am pleased to share that JSS continues to go from strength to strength, achieving a 2025 CiteScore of 2.6 and its first Journal Impact Factor of 2.3. These important milestones reinforce JSS’s growing position as a major international journal within the spine surgery publishing landscape.

JSS has also expanded to monthly publication, supported by a streamlined review process designed to facilitate timely peer review and more rapid publication of accepted manuscripts.

I extend my sincere thanks to all our authors, reviewers, Editorial Board members, and readers whose continued contributions have made the journal’s success possible.

We warmly invite you to consider JSS for your future work as the journal continues to grow.

Over the past few years, I have enjoyed serving on the Editorial Board of Current Challenges in Thoracic Surgery and watching the journal continue to grow. It is encouraging to see the hard work of the editorial team, reviewers, and authors recognized with this important milestone.

What I value most about CCTS is its emphasis on practical and clinically meaningful topics. The journal has become a place where surgeons can share new techniques, discuss challenging cases, and publish research that is directly relevant to everyday thoracic practice.

I am confident CCTS will continue to grow and attract high-quality contributions from colleagues around the world. I look forward to supporting the journal as it continues to develop and wishes the entire CCTS team continued success.

I am pleased to congratulate the Journal of Spine Surgery on achieving its first Impact Factor. This is an important milestone and a meaningful recognition of the work carried out by the editorial team, reviewers, authors, and contributors over the years.

In a field such as spine surgery, where clinical practice, technology, biomechanics, and outcomes research continue to evolve rapidly, JSS has built an important role as an international platform for rigorous and clinically relevant academic discussion.

As an Editorial Board Member, I am honored to contribute to the journal’s development and I look forward to seeing JSS further strengthen its scientific impact and international visibility.

It is encouraging to see VATS receive its latest impact factor and CiteScore. These are welcome milestones, but the journal’s main value remains its focus on clinically relevant work in minimally invasive thoracic surgery.

As Editor-in-Chief, I hope VATS will keep attracting thoughtful submissions and publishing work that is useful to surgeons in daily practice. I am grateful to everyone who has contributed to the journal so far, and I look forward to seeing it continue to grow.

I've enjoyed being part of VATS's editorial board and seeing how the journal has evolved. Going forward, I'd like to see more submissions from surgical teams outside the usual high-volume centers; that's often where the most honest data on real-world outcomes comes from. Congratulations on the progress so far.

Pediatric Medicine has received its first impact factor. This represents a milestone in the journal’s development. The mission of PM is to bring pediatricians, at the intersection of clinical practice and translational research, to ultimately improve health care delivery and promote children’s health. The new impact factor demonstrates that this ambitious goal is within reach.

As Editor-in-Chief of the journal Neonatology, I am a close observer of the rise of Chinese neonatology. In my opinion there is a need for a Chinese based journal of Pediatrics, as Pediatric Medicine, in order to absorb the rapid growth in high quality scientific manuscripts coming from PRC. When combining this with an international perspective the future of PM is bright.